{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:18:02Z","timestamp":1789075082247,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Dicyclohexylcarbodiimide (DCC) is known to cause occupational allergic contact dermatitis in biotechnology laboratory workers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to assess the prevalence of DCC sensitization among workers of one biosynthesis laboratory and to determine the optimal DCC concentration for patch testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>23 laboratory workers frequently exposed to DCC of whom 21 suffered from dermatitis and 11 controls were enrolled into the study. All participants underwent skin patch testing with different concentrations of DCC and other substances used in the work environment. Statistical analysis was conducted to compare results between active and control groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 23 workers tested, 56.5% showed positive reactions to DCC. All of them had dermatitis. Morpholine also elicited positive reactions in 26.1% of workers who were all sensitized to DCC. Dimethylformamide and chloroform yielded negative results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Dicyclohexylcarbodiimide was a major cause of contact dermatitis in the active group indicating an outbreak of contact allergy to DCC in the company necessitating preventive measures. Both DCC 0.1% ac. and DCC 0.05% pet. should both be used for patch testing.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cod.14715","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T02:39:33Z","timestamp":1730169573000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory"],"prefix":"10.1111","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9099-899X","authenticated-orcid":false,"given":"Linas","family":"Griguola","sequence":"first","affiliation":[{"name":"Pulmonology and Allergology Center, VUH Santaros Klinikos  Vilnius Lithuania"},{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestutis","family":"Cerniauskas","sequence":"additional","affiliation":[{"name":"Pulmonology and Allergology Center, VUH Santaros Klinikos  Vilnius Lithuania"},{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-5915","authenticated-orcid":false,"given":"Laura","family":"Malinauskiene","sequence":"additional","affiliation":[{"name":"Pulmonology and Allergology Center, VUH Santaros Klinikos  Vilnius Lithuania"},{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotryna","family":"Linauskiene","sequence":"additional","affiliation":[{"name":"Pulmonology and Allergology Center, VUH Santaros Klinikos  Vilnius Lithuania"},{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Rudyte","sequence":"additional","affiliation":[{"name":"Pulmonology and Allergology Center, VUH Santaros Klinikos  Vilnius Lithuania"},{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzelika","family":"Chomiciene","sequence":"additional","affiliation":[{"name":"Pulmonology and Allergology Center, VUH Santaros Klinikos  Vilnius Lithuania"},{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1","volume-title":"Contact Dermatitis","author":"Frosch PJ","year":"2020"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80054-4"},{"issue":"6","key":"e_1_2_8_4_1","first-page":"212","article-title":"Contact allergy to dicyclohexylcarbodiimide and N\u2010hydroxyphthalimide","volume":"35","author":"Lang MH","year":"1987","journal-title":"Dermatosen Beruf Umw Occup Environ"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1983.tb04403.x"},{"issue":"1","key":"e_1_2_8_6_1","first-page":"51","article-title":"Acute dermatitis after contact with dicyclohexylcarbodiimide","volume":"10","author":"Vente C","year":"1999","journal-title":"Am J Contact Dermat Off J Am Contact Dermat Soc"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/01480549809011647"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.00971.x"},{"key":"e_1_2_8_9_1","unstructured":"U.S. department of health and human services toxicology studies of dicyclohexylcarbodiimide (CAS NO. 538\u201075\u20100).2007https:\/\/ntp.niehs.nih.gov\/sites\/default\/files\/ntp\/htdocs\/gmm_rpts\/gmm9.pdf. Accessed May 28 2023."},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13965"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-02035-3_82"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.190501"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2009.11.006"},{"key":"e_1_2_8_14_1","unstructured":"Patch testing vierde editie Anton de Groot\/Ton de Groot.2018https:\/\/www.antondegroot.com\/science\/publications\/books\/book-patch-testing-1986-2022\/patch-testing-fourth-edition. Accessed July 5 2024."},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12432"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-382239-0.00004-2"},{"key":"e_1_2_8_17_1","unstructured":"PubChem.Dicyclohexylcarbodiimide.2023https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/10868. Accessed May 31 2023."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.2c00031"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1979.tb04874.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1979.tb04892.x"},{"key":"e_1_2_8_21_1","unstructured":"NIOSH skin notation (SK) profile: morpholine [CAS No. 110\u201091\u20108].2023https:\/\/www.cdc.gov\/niosh\/docs\/2017-137\/default.html. Accessed July 24 2024."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1988.tb02861.x"},{"key":"e_1_2_8_23_1","first-page":"210","article-title":"Laboratory safety and biohazards","volume":"7","author":"Ribes R","year":"2009","journal-title":"Engl Biomed Sci"},{"key":"e_1_2_8_24_1","unstructured":"Good Laboratory Practice.https:\/\/single-market-economy.ec.europa.eu\/sectors\/chemicals\/good-laboratory-practice_en. Accessed June 4 2023."},{"key":"e_1_2_8_25_1","unstructured":"OECD Series on Principles of Good Laboratory Practice (GLP) and Compliance Monitoring \u2013 OECD.https:\/\/www.oecd.org\/chemicalsafety\/testing\/oecdseriesonprinciplesofgoodlaboratorypracticeglpandcompliancemonitoring.htm. Accessed June 4 2023."},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/493009a"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cod.14715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:25:53Z","timestamp":1736382353000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cod.14715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/cod.14715"],"URL":"https:\/\/doi.org\/10.1111\/cod.14715","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"2024-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}